Faces of Digital Health

AI is the buzzword startups are very keen on using when describing their products. For decades, movies are full of ideas on what artificial intelligence could do in a positive and negative way. What is AI, deep learning or a simple algorithm? What is the dream and what current reality around AI? How does AI look in practice? In this episode, you will hear from Sally Daub - the CEO of Enlitic talk about the market potential of AI, the current state of the market and more. Enlitic is a San Francisco based startup using deep learning to distill actionable insights from billions of clinical cases and help doctors leverage the collective intelligence of the medical community. At the moment, the use of AI is highest in the field of medical imaging and diagnostics, drug discovery and therapy planning, but Accenture predicts that by 2026 150 billion US dollars could be saved annually due to applications to robot-assisted surgery, virtual nursing assistants, followed by administrative workflow assistance, fraud detection and dosage error reduction, to name the first few areas with most significant savings.

In this episode, two Americans share their insight in the healthcare development of the land with 1,4 billion people. Bay McLaughlin, Forbes contributor on tech in China and the co-founder of Brinc.io, part incubator, part accelerator, part investment fund with headquarters located in Hong Kong, Shenzhen, and Guangzhou and satellite offices in mainland China, also London, Berlin, Helsinki, Amsterdam & soon in the USA. Miranda Gottlieb, Master’s student from Beijing, pursuing a career in global health policy and health security in the Asia-Pacific region.

According to dr. Walter Greenleaf, behavioral neuroscientist and a medical technology developer working at Stanford University, interactive virtual environments significantly reduce pain from as much as 44% during the most painful procedures (ex: burn wound treatment), diverts patient attention away from perceiving and feeling pain, decreases pain-related brain-activity, reduces need for anesthesia, opioid medication. With the decrease in price, VR is getting mainstream. The technology giants such as Facebook and Samsung are making huge investments, according to Statista, 12.4 million units will be shipped worldwide in 2018, more than 5 times as much in 4 years in 2022. Listen to a conversation with dr. Walter Greenleaf, Medical Director for AppliedVR at Stanford University. He is considered a leading authority in the medical VR field with over three decades of research and development experience in the field of digital medicine and medical virtual reality technology.

Virtual reality has a long history. Its applications precede pure fun, by today, many therapies for medical purposes have been designed. Virtual reality has many medical applications, which you can learn about from two experts featured in Facs of digital health podcast. In episode 10 listen to dr. Albert “Skip” Rizzo, the Director of Medical Virtual Reality at the Institute for Creative Technologies at University of Southern California, and episode 12 features dr. Walter Greenleaf, the Medical Director for AppliedVR at Stanford University. Topics: addressed: How does VR differ from exposure therapy, is it more effective? What are the dangers of VR use on perception? How do you treat ADHD or PTSD with VR?  Will FDA regulate VR treatments? What danger do consumers currently face?

The two largest determinants of health are the zip code and credit scores. What does that have to do with precision medicine and genetics? Big data combined with AI hold a lot of hope on prevention and more effective disease treatments. The current reality though is that large a lot of gathered data is not actionable yet. How far is precision medicine then, today? How does precision medicine based medical care look like? Tune in episode 9 of Faces of digital health with dr. Subha Madhavan. Dr. Madhavan is the Director of the Innovation Center for Biomedical Informatics (ICBI) at the Georgetown University Medical Center in the States. She is active in several national and international research projects, and one of her latest projects is a partnership with the Food & Drug Administration (FDA) to develop evidence bases for pharmacogenomics and vaccine safety.

A sex hunting anthropologist walks into a mortgage finance institution and out into the world to lead health initiatives globally; this is the fascinating tale of Samson Williams’ health career journey. Samson Williams is an entrepreneur and fintech guru. He has been an epidemiologist for the State of Florida, an Anthrax and WMD expert for DC Dept of Health and currently splits his time between serving on the DC Dept of Health’s Institutional Review Board (IRB), and as the Irish Ambassador for Crowdfunding to the EU and partner at Axes and Eggs, a blockchain and cryptocurrency consultancy based in Washington, DC.   Topics addresses:  How does one go from medical anthropology to a cryptocurrency mining company? How can digital health solutions help in disaster situations?  Potential of blockchain in healthcare?

This is a recording of a panel discussion on blockchain in healthcare, which took place at the SXSW festival in Austin, Texas, during the Future for health conference at SXSW. You will hear about some interesting ongoing blockchain projects such as the CDC attempts to use blockchain in epidemiology or the Austin program using blockchain to track medical records of chronically ill homeless people. Panelists:  Michael Dillhyon, Founder of Healthbank Samson Williams, Partner at Axes & Eggs, Board Member at DC Department of Health Eugene Borukhovich, Global Head of Digital Health Incubation & Innovation at Bayer

“Most startups are in a hurry, most of healthcare not so much. How do we deal with that?” was one of the first questions with which Rasu Shrestha, CIO at UPMC addressed his audience during the Future for health at SXSW conference in Austin, Texas. With the keynote titled “Everybody wants to innovate, nobody wants to change,” Rasu Shrestha offered his reflection on the barriers to innovation implementation. The organizer of the conference was Future for health (FTR4H), a global organization trying to bridge the robust established Medtech world with young startups. To understand FTR4H a little bit better, a short talk with the co-founder of Future for health Tom Mitchell, president of Messe Dusseldorf North America is included in the podcast. Tom talked on stage at the Future for health conference at SXSW, right before Rasu’s keynote.

In this episode, you will hear how Time Warner, a global leader in media and entertainment with businesses in television networks and film and TV entertainment, is approaching employee health. Time Warner has more than 25.000 employees around the globe, meaning that the company faces many different country-specific regulations when it comes to the health of employees, what programmes they can offer them and what kind of analysis they can do with the data of the employees. his year's big question in healthcare is - can big corporations be the disruptors of the rigid and risk-averse industry as healthcare is? Amazon partnered with JPMorgan Chase and Warren Buffett, Apple is designing medical clinics, and Uber wants to disrupt ambulances. The healthcare industry is worth close to 9 trillion dollars globally by 2020, and some say tech giants most of all wish to get a piece of this pie. However, the critical potential for the US is a decrease in cost with new solutions and the different approach companies can have towards their employees' health. In this episode: Kathleen Harris, Vice President of Benefits at Time Warner.

According to WHO mental health disorders are generally characterized by some combination of abnormal thoughts, emotions, behaviour and relationships with others. Examples are schizophrenia, depression, intellectual disabilities and disorders due to drug abuse. Most of these disorders can be successfully treated. This episode explores the characteristics of mental health disorders and why it is so hard to treat them. Hear from three speakers: Dean Ornish, Clinical Professor in Medicine, President and Director of the Preventive Medicine Research Institute at University of California Sans Francisco talks about the critical aspect of depression, which is the changes in perception that prevent a depressed person to see the light at the end of the tunnel. The Co-founder and CEO of Psyinnovations Ritvik Singh talks about the broadness of mental health challenges and to which extent digital solutions can help address them. Richard Lee, the CEO of a startup called Bravely, believes regular 5-minute power calls with peers can have a significant positive effect on individuals wellbeing. This is what Bravely does: short, peer to peer phone support as a replacement traditional psychotherapeutic counselling.